1. Home
  2. ADAP vs MYFW Comparison

ADAP vs MYFW Comparison

Compare ADAP & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • MYFW
  • Stock Information
  • Founded
  • ADAP 2008
  • MYFW 2002
  • Country
  • ADAP United Kingdom
  • MYFW United States
  • Employees
  • ADAP N/A
  • MYFW N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • MYFW Major Banks
  • Sector
  • ADAP Health Care
  • MYFW Finance
  • Exchange
  • ADAP Nasdaq
  • MYFW Nasdaq
  • Market Cap
  • ADAP 158.6M
  • MYFW 170.9M
  • IPO Year
  • ADAP 2015
  • MYFW 2018
  • Fundamental
  • Price
  • ADAP $0.56
  • MYFW $19.57
  • Analyst Decision
  • ADAP Strong Buy
  • MYFW Buy
  • Analyst Count
  • ADAP 4
  • MYFW 3
  • Target Price
  • ADAP $2.79
  • MYFW $21.83
  • AVG Volume (30 Days)
  • ADAP 623.5K
  • MYFW 26.6K
  • Earning Date
  • ADAP 03-05-2025
  • MYFW 04-17-2025
  • Dividend Yield
  • ADAP N/A
  • MYFW N/A
  • EPS Growth
  • ADAP N/A
  • MYFW N/A
  • EPS
  • ADAP N/A
  • MYFW 0.26
  • Revenue
  • ADAP $175,041,000.00
  • MYFW $79,649,000.00
  • Revenue This Year
  • ADAP $204.91
  • MYFW N/A
  • Revenue Next Year
  • ADAP N/A
  • MYFW $10.84
  • P/E Ratio
  • ADAP N/A
  • MYFW $75.18
  • Revenue Growth
  • ADAP 146.27
  • MYFW N/A
  • 52 Week Low
  • ADAP $0.53
  • MYFW $12.84
  • 52 Week High
  • ADAP $2.05
  • MYFW $22.32
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 40.12
  • MYFW 42.09
  • Support Level
  • ADAP $0.55
  • MYFW $20.60
  • Resistance Level
  • ADAP $0.61
  • MYFW $21.70
  • Average True Range (ATR)
  • ADAP 0.03
  • MYFW 0.62
  • MACD
  • ADAP -0.00
  • MYFW -0.16
  • Stochastic Oscillator
  • ADAP 12.14
  • MYFW 2.80

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

Share on Social Networks: